128 related articles for article (PubMed ID: 34347730)
1. Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer: Update of a Nationwide Cohort.
Rijken A; Bakkers C; van Erning FN; van der Geest LG; de Vos-Geelen J; Besselink MG; Lemmens VE; de Hingh IHJT;
Pancreas; 2021 Jul; 50(6):827-833. PubMed ID: 34347730
[TBL] [Abstract][Full Text] [Related]
2. Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort.
Koemans WJ; Lurvink RJ; Grootscholten C; Verhoeven RHA; de Hingh IH; van Sandick JW
Gastric Cancer; 2021 Jul; 24(4):800-809. PubMed ID: 33495964
[TBL] [Abstract][Full Text] [Related]
3. Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study.
Thomassen I; Lemmens VE; Nienhuijs SW; Luyer MD; Klaver YL; de Hingh IH
Pancreas; 2013 Jan; 42(1):72-5. PubMed ID: 22850624
[TBL] [Abstract][Full Text] [Related]
4. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
[TBL] [Abstract][Full Text] [Related]
5. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
[TBL] [Abstract][Full Text] [Related]
6. Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases.
Simkens GA; Razenberg LG; Lemmens VE; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2016 Jun; 42(6):794-800. PubMed ID: 27055946
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
Rijken A; Pape M; Simkens GA; de Hingh IHJT; Luyer MDP; van Sandick JW; van Laarhoven HWM; Verhoeven RHA; van Erning FN
Int J Cancer; 2024 Mar; 154(6):992-1002. PubMed ID: 37916797
[TBL] [Abstract][Full Text] [Related]
8. Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: Results of a population-based study.
Razenberg LG; Lemmens VE; Verwaal VJ; Punt CJ; Tanis PJ; Creemers GJ; de Hingh IH
Eur J Cancer; 2016 Sep; 65():113-20. PubMed ID: 27497343
[TBL] [Abstract][Full Text] [Related]
9. Implications of peritoneal cytology for pancreatic cancer management.
Makary MA; Warshaw AL; Centeno BA; Willet CG; Rattner DW; Fernández-del Castillo C
Arch Surg; 1998 Apr; 133(4):361-5. PubMed ID: 9565114
[TBL] [Abstract][Full Text] [Related]
10. Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer.
Piso P; Stierstorfer K; Gerken M; Klinkhammer-Schalke M
Int J Colorectal Dis; 2018 Nov; 33(11):1559-1567. PubMed ID: 30132068
[TBL] [Abstract][Full Text] [Related]
11. Synchronous peritoneal metastases from lung cancer: incidence, associated factors, treatment and survival: a Dutch population-based study.
Lurvink RJ; Rijken A; Bakkers C; Aarts MJ; Kunst PWA; van de Borne BE; van Erning FN; de Hingh IHJT
Clin Exp Metastasis; 2021 Jun; 38(3):295-303. PubMed ID: 33738641
[TBL] [Abstract][Full Text] [Related]
12. Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database.
Rijken A; Bakkers C; Klümpen HJ; van der Geest LG; de Vos-Geelen J; van Erning FN; de Hingh IHJT
Eur J Surg Oncol; 2023 Aug; 49(8):1436-1443. PubMed ID: 36898900
[TBL] [Abstract][Full Text] [Related]
13. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
Lurvink RJ; Bakkers C; Rijken A; van Erning FN; Nienhuijs SW; Burger JW; Creemers GJ; Verhoef C; Lemmens VE; De Hingh IH
Eur J Surg Oncol; 2021 May; 47(5):1026-1033. PubMed ID: 33272737
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.
Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH
Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733
[TBL] [Abstract][Full Text] [Related]
15. Survival of breast cancer patients with synchronous or metachronous central nervous system metastases.
Ho VK; Gijtenbeek JM; Brandsma D; Beerepoot LV; Sonke GS; van der Heiden-van der Loo M
Eur J Cancer; 2015 Nov; 51(17):2508-16. PubMed ID: 26277099
[TBL] [Abstract][Full Text] [Related]
16. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin.
Thomassen I; Verhoeven RH; van Gestel YR; van de Wouw AJ; Lemmens VE; de Hingh IH
Eur J Cancer; 2014 Jan; 50(1):50-6. PubMed ID: 24011935
[TBL] [Abstract][Full Text] [Related]
17. Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis.
Mackay TM; van Erning FN; van der Geest LGM; de Groot JWB; Haj Mohammad N; Lemmens VE; van Laarhoven HW; Besselink MG; Wilmink JW;
Eur J Cancer; 2019 Jan; 106():99-105. PubMed ID: 30476732
[TBL] [Abstract][Full Text] [Related]
18. Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based study.
Rovers KP; Simkens GA; Vissers PA; Lemmens VE; Verwaal VJ; Bremers AJ; Wiezer MJ; Burger JW; Hemmer PH; Boot H; van Grevenstein WM; Meijerink WJ; Aalbers AG; Punt CJ; Tanis PJ; de Hingh IH;
Eur J Cancer; 2017 Apr; 75():132-140. PubMed ID: 28222307
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: A nationwide comparative study.
Bakkers C; van Erning FN; Rovers KP; Nienhuijs SW; Burger JW; Lemmens VE; Aalbers AG; Kok NF; Boerma D; Brandt AR; Hemmer PH; van Grevenstein WM; de Reuver PR; Tanis PJ; Tuynman JB; de Hingh IH
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1902-1907. PubMed ID: 32340819
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases.
Rovers KP; Bakkers C; van Erning FN; Burger JWA; Nienhuijs SW; Simkens GAAM; Creemers GM; Hemmer PHJ; Punt CJA; Lemmens VEPP; Tanis PJ; de Hingh IHJT
JAMA Oncol; 2020 Aug; 6(8):e202701. PubMed ID: 32672798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
